The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%
The girl child anthem will portray a celebration of a girl child.
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
The move will add new global talent to Cytel’s Strategic Consulting group
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.
Monetary awards worth Rs 1.20 crore were presented amongst the winners for their remarkable contributions
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Subscribe To Our Newsletter & Stay Updated
